Strata Critical Medical Inc. (SRTA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Strata Critical Medical I...

NASDAQ: SRTA · Real-Time Price · USD
5.41
0.18 (3.44%)
At close: Oct 03, 2025, 3:59 PM
5.42
0.18%
Pre-market: Oct 06, 2025, 08:03 AM EDT

Strata Critical Medical Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q3 2021 Q4 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-18.98M -26.57M -27.31M -51.45M -49.21M -50.12M -56.08M -37.55M -47.08M -26.44M -27.26M -21.03M -11.01M -43.71M -33.78M -26.96M -27.83M -3.55M
Depreciation & Amortization
6.28M 6.07M 5.96M 6.24M 6.8M 7.05M 7.11M 7.29M 6.89M 6.23M 5.72M 3.93M 3.21M 2.05M 908.4K 856.4K 665.4K 665K
Stock-Based Compensation
19.49M 19.79M 19.89M 18.52M 16.45M 13.6M 12.5M 12M 10.35M 9.4M 8.28M 9.55M 10.8M 8.96M 6.86M 4.21M 1.77M 1.76M
Other Working Capital
-5.03M 8.8M -2.01M 347K 3.79M -2.16M 3.52M 9.68M 7.6M 853K 5.33M -1.5M 524K 335.36M 334.7M 336.79M 334.77M 1.67M
Other Non-Cash Items
-2.64M 3.79M 2.2M 20.92M 14.27M 9.21M 12.32M -11.07M -4.07M -22.53M -23.08M -20.51M -31.19M -322.4M -319.13M -318.89M -308.78M 56.1K
Deferred Income Tax
-219K -188K -255K -1.17M -926K -1.35M -1.47M -1.22M -1.34M -968K -772K n/a -108K -108K -108K -108K 0.00 n/a
Change in Working Capital
-2.64M 9.9M -3.01M -3.14M -1.8M -9.44M -6.74M -1.58M -5.25M -9.61M -17K -5.76M -5.18M 333.32M 333.07M 334.5M 333.67M 571.23K
Operating Cash Flow
1.29M 12.79M -2.52M -10.09M -14.42M -31.05M -32.35M -32.13M -40.51M -43.92M -37.13M -33.82M -33.48M -21.88M -12.18M -6.39M -500.24K -496.76K
Capital Expenditures
-20.84M -35.02M -32.99M -27.98M -18.75M -2.59M -2.11M -2.1M -1.49M -939K -730K -787K -918K -729.23K -292.23K -760.23K -913.23K -913K
Cash Acquisitions
n/a n/a n/a -39K -39K -39K -39K n/a n/a n/a n/a n/a -12.36M -12.36M -12.36M -12.36M n/a n/a
Purchase of Investments
-162.61M -150.4M -143.25M -142.77M -212.74M -212.75M -265.97M -373.5M -377.84M -378.02M -248.02M -146.1M -6.06M -6.18M -5.91M -303.16K -303.16K n/a
Sales Maturities Of Investments
226.01M 182.46M 177.45M 167.95M 236.09M 240.62M 285.07M 393.07M 319.4M 511.87M 376.38M 268.38M 225.91M 28.91M 17.21M 17.21M n/a n/a
Other Investing Acitivies
-4.17M -4.55M -4.34M -3.75M -918K -173K 138K n/a -48.29M -48.29M -48.29M -60.06M -11.77M -11.77M -11.77M -503.5K -503.5K -503K
Investing Cash Flow
40.42M -5.17M -1.02M -4.92M 4.69M 25.38M 17.09M 17.48M -108.23M 84.62M 79.34M 61.44M 194.81M -2.12M -13.12M 3.79M -1.22M -913K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-10M -10.06M -5.76M -1.91M -1.18M 5K -76K -53K -199K -1.13M -1.08M -903K -3.71M -2.43M -2.45M -4.03M 111.05K -221K
Financial Cash Flow
-9.99M -10.06M -5.76M -1.91M -1.18M 5K -76K -53K -199K -1.13M -1.08M -903K -3.71M -2.43M -2.45M -4.03M 111.08K -221K
Net Cash Flow
31.95M -2.37M -9.37M -16.87M -11.03M -5.76M -15.4M -14.71M -148.85M 39.64M 41.2M 26.71M 157.61M -27.27M -28.58M -7.47M -3.24M -2.43M
Free Cash Flow
-19.55M -22.23M -35.51M -38.06M -33.17M -33.63M -34.46M -34.23M -42M -44.86M -37.86M -34.6M -34.4M -22.61M -12.47M -7.15M -1.41M -1.41M